Stay updated on HY209 Gel Phase I Clinical Trial
Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.

Latest updates to the HY209 Gel Phase I Clinical Trial page
- Check3 days agoChange DetectedOnly a site revision update from v3.4.0 to v3.4.1 is visible, with no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded a glossary toggle; updated several UI labels for capitalization (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'); and updated the footer revision from v3.3.4 to v3.4.0. These are formatting and metadata updates that do not modify study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now shows an updated site revision line: Revision: v3.3.4 (replacing v3.3.3). This is a minor metadata update and does not affect the clinical trial details, eligibility criteria, enrollment, or results.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded: Revision: v3.3.3 and removed: HHS Vulnerability Disclosure and Revision: v3.3.2. The changes pertain to site-wide release notes/footer and do not affect the Study Details content or its purpose.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedA notice about government funding status and potential delays at the top of the page was removed. The rest of the study details and navigation appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to HY209 Gel Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.